Zoekresultaten - 8 results

Potential impact fractions of body mass index reductions on the non-communicable disease burden in Belgium using G-computation

reduction scenarios in the Belgian adult population. Methods: Data from the Belgian health interview surveys 2013/2018 (n=18 212) were linked with objective environmental factors based on the residential ...

A healthy lifestyle is positively associated with mental health and well-being and core markers in ageing

its effect on core markers of ageing: telomere length (TL) and mitochondrial DNA content (mtDNAc). METHODS: In this study, 6054 adults from the 2018 Belgian Health Interview Survey (BHIS) were included. ...

Variation in smoking attributable all-cause mortality across municipalities in Belgium, 2018: application of a Bayesian approach for small area estimations

smoking prevalence in each Belgian municipality using BHIS and calculate smoking attributable mortality at municipality level. Methods Data of participants aged 15 + on smoking behavior, age, gender, ...

COVID-19 and people who use drugs: Impact of the pandemic on general anxiety and depressive disorders among adults in Belgium.

and depressive disorders among PWUD. Furthermore, we wanted to compare the prevalence of these disorders with that of members from the general population who did not use drugs. METHODS: We used ...

Women's views on barriers and facilitators for seeking alcohol and drug treatment in Belgium.

study in Belgium was to identify and obtain a better understanding of the barriers and facilitators for seeking treatment as experienced by substance (ab)using women themselves. Methods: In-depth ...

Potential impact of reduced tobacco use on life and health expectancies in Belgium

Abstract: Objectives We investigated the potential impact of reduced tobacco use scenarios on total life expectancy and health expectancies, i.e., healthy life years and unhealthy life years. Methods Data ...

Trends in primary substance mentioned by patients entering treatment for illicit substance use in Belgium between 2012 and 2018

primary drug mentioned for treatment in Belgium between 2012 and 2018 globally as well as in different subgroups of patients. Methods The Belgian Treatment Demand Indicator database (TDI) collects ...

QR code

QR code for this page URL